Mitochondrial Complex III ROS Regulate Adipocyte Differentiation  by Tormos, Kathryn V. et al.
Cell Metabolism
Short ArticleMitochondrial Complex III ROS
Regulate Adipocyte Differentiation
Kathryn V. Tormos,1 Elena Anso,1 Robert B. Hamanaka,1 James Eisenbart,1 Joy Joseph,4 Balaraman Kalyanaraman,4
and Navdeep S. Chandel1,2,3,*
1Division of Pulmonary and Critical Care, Department of Medicine
2Robert H. Lurie Comprehensive Cancer Center
3Department of Cell and Molecular Biology
Northwestern University Medical School, Chicago, IL 60611, USA
4Department of Biophysics and Free Radical Research Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA
*Correspondence: nav@northwestern.edu
DOI 10.1016/j.cmet.2011.08.007SUMMARY
Adipocyte differentiation is characterized by an
increase in mitochondrial metabolism. However, it
is not known whether the increase in mitochondrial
metabolism is essential for differentiation or a by-
product of the differentiation process. Here, we
report that primary human mesenchymal stem cells
undergoing differentiation into adipocytes display
an early increase in mitochondrial metabolism, bio-
genesis, and reactive oxygen species (ROS) genera-
tion. This early increase in mitochondrial metabolism
and ROS generation was dependent on mTORC1
signaling. Mitochondrial-targeted antioxidants in-
hibited adipocyte differentiation, which was rescued
by the addition of exogenous hydrogen peroxide.
Genetic manipulation of mitochondrial complex III
revealed that ROS generated from this complex is
required to initiate adipocyte differentiation. These
results indicate that mitochondrial metabolism and
ROS generation are not simply a consequence of
differentiation but are a causal factor in promoting
adipocyte differentiation.
INTRODUCTION
Adipocytes are dynamic reservoirs for energy homeostasis in
mammals. There are two types of adipose tissue, white adipose
tissue (WAT) and brown adipose tissue (BAT) (Gesta et al., 2007).
White adipocytes function primarily to store triglycerides as
energy (Spiegelman and Flier, 2001), while brown adipocytes
generate heat energy at the expense of ATP generation due to
their high expression of the uncoupling protein UCP1 (Cannon
and Nedergaard, 2004). Mesenchymal stem cells give rise to
distinct white and brown adipocyte precursors (Park et al.,
2008). Brown adipocytes share precursors with muscle cells,
but not with white adipocytes (Seale et al., 2008). The transcrip-
tion factors PPARg and C/EBPa drive white adipocyte differen-
tiation, while the transcriptional regulators PRDM16 and PPARg
drive brown fat differentiation (Tontonoz and Spiegelman, 2008).CellAlthough much progress has been made in understanding the
transcriptional program that induces adipogenesis, the signaling
mechanisms underlying the activation of transcriptional ma-
chinery are not fully understood.
During adipogenesis, autophosphorylation of insulin/IGF-1
receptor tyrosine kinases in the presence of insulin initiates
glucose transport, glucose metabolism, proadipogenic gene
transcription, and de novo lipid synthesis (Saltiel and Kahn,
2001). Akt activation downstream of insulin signaling makes
multiple contributions to adipocyte differentiation and is required
for the process (Peng et al., 2003). Mammalian target of rapamy-
cin (mTOR) complex 1 is one output of Akt signaling required for
adipogenesis (Gagnon et al., 2001). Rapamycin-mediated inhibi-
tion of mTORC1 diminishes protein levels of PPARg and C/EBPa
and adipogenesis in vitro (Kim and Chen, 2004). Depletion of
Raptor by RNAi results in diminished mTORC1 activity and
reduced adipogenesis (Polak et al., 2008). By contrast, hyperac-
tivation of mTORC1 due to loss of TSC2 increases PPARg and
C/EBPamRNA and protein expression to promote adipogenesis
in vitro (Zhang et al., 2009). mTORC1-dependent protein transla-
tion is one likely mechanism that contributes to the control of
adipogenic transcriptional machinery (Carnevalli et al., 2010).
Nevertheless, our current understanding of how mTORC1
controls the adipogenic transcriptional machinery is still incom-
plete. One output of activated mTORC1 is to positively regulate
mitochondrial oxygen consumption in mammalian cells (Schieke
et al., 2006). Mitochondrial oxygen consumption and overall
reactive oxygen species (ROS) levels both increase during
adipogenesis (Imhoff and Hansen, 2010; Wilson-Fritch et al.,
2003). However, it is not known whether these increases are
causal for promoting adipocyte differentiation. In the present
study, we tested whether mitochondrial ROS are required to
initiate the PPARg transcriptional machinery downstream of
mTORC1 activation during differentiation of human mesen-
chymal stem cells (MSCs) into adipocytes.
RESULTS
Mitochondrial-Targeted Antioxidants Diminish
Adipocyte Differentiation
Primary human MSCs isolated from bone marrow display robust
lipid accumulation within 21 days when exposed to a combina-
tion of indomethacin, dexamethasone isobutylmethylxanthineMetabolism 14, 537–544, October 5, 2011 ª2011 Elsevier Inc. 537
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Figure 1. Mitochondrial-Targeted Antioxidants Diminish Adipocyte Differentiation
(A) Mitochondrial OCRs of human MSCs at days 0 (4 hr), 2, and 7 of adipocyte differentiation. Cells were treated with FCCP (10 mM) to obtain maximal OCRs.
N = 4 ± SEM.
(B) Intracellular H2O2 levels of human MSCs at day 0 (4 hr) and day 2 of differentiation. Cells were treated with 500 nM of TPP or MitoCP for 4 hr prior to
measurement on day 2. N = 4 ± SEM.
(C) Mitochondrial-targeted antioxidants MitoCP and MCTPO attenuate lipid accumulation. Human MSCs were treated with 500 nM of TPP control and mito-
chondrial-targeted antioxidants MitoCP or MitoCTPO starting at day 2 of differentiation. Subsequently, optical density (OD) values of oil red O were assessed at
day 21. N = 3 ± SEM.
(D) Mitochondrial-targeted antioxidants MitoQ and Mito-Tempol diminish lipid accumulation. Human MSCs were treated starting at day 2 of differentiation with
500 nM of Mito-Tempol C10, Mito-Q, Mito CP, or TPP control. Subsequently, at day 21 of differentiation cells were stained with oil red O and optical density (OD)
values were assessed. N = 3 ± SEM.
(E) Western blot analysis of PPARg and C/EBPa protein at days 2, 5, and 7 of differentiation in humanMSCs treated with 500 nM of MitoCP or TPP starting at day
2. Day 2 cells were lysed after 4 hr of MitoCP or TPP treatment.
(F) Gene expression of PPARg2 and its target genes at day 7 of differentiation in humanMSCs treated with 500 nMMitoCP or TPP starting at day 2. N = 3 ± SEM.
Cell Metabolism
Mitochondrial ROS Regulate Adipogenesis(IBMX), and insulin (INS) (Pittenger et al., 1999). We observed
a gradual increase in the basal and maximal oxygen consump-
tion rate (OCR) of human MSCs exposed to adipogenic medium
over 7 days (Figure 1A). Most of the basal OCR was coupled to
the generation of ATP synthesis, indicating that these cells
display hallmarks of white adipocytes (data not shown). We
hypothesized that an increase in mitochondrial OCR would be
accompanied by an increase in ROS levels. Indeed, an intracel-
lular increase of H2O2 was observed at day 2 of differentiation
compared to Day 0 control human MSCs (Figure 1B). The
increase in intracellular H2O2 was attenuated in the presence
of the mitochondrial-targeted antioxidant MitoCP (Figure 1B).
This nitroxide-based antioxidant is targeted to the mitochondria
by the covalent coupling of its nitroxide moiety to a triphenyl-
phosphonium cation (TPP), which serves as a control compound
(Dhanasekaran et al., 2005). These results indicate that an
increase in mitochondrial oxygen consumption and an increase538 Cell Metabolism 14, 537–544, October 5, 2011 ª2011 Elsevier Inin intracellular ROS are early events during humanMSC differen-
tiation into adipocytes.
To test whether the increase in mitochondrial-generated ROS
is required for adipocyte differentiation, human MSCs were
treated with the control TPP and mitochondria-targeted antioxi-
dants MitoCP or MitoCTPO starting at day 2 of differentiation.
We began adipocyte treatment with mitochondrial-targeted
antioxidants starting at day 2 to avoid interference with mitotic
clonal expansion previously noted during adipocyte differen-
tiation (Gagnon et al., 2001). This allows us to examine whether
mitochondrial ROS regulate adipocyte differentiation indepen-
dent of early proliferative signaling. A significant reduction in
lipid accumulation was observed in adipocytes treated with
mitochondrial antioxidants (500 nM) (Figure 1C). The decrease
in lipid accumulation by MitoCP and MitoCTPO was concen-
tration dependent (see Figure S1A available online). Lipid accu-
mulation was also inhibited in adipocytes treated with otherc.
Cell Metabolism
Mitochondrial ROS Regulate Adipogenesiswell-characterized mitochondria-targeted antioxidants Mito-Q
and Mito-Tempol C10 (Figure 1D). In conjunction with lipid
accumulation, protein levels of major adipogenic transcription
factors CCAAT/enhancer-binding protein alpha (C/EBPa) and
peroxisome proliferator-activated receptor gamma 2 (PPARg2)
were decreased in the presence of MitoCP compared to TPP
controls (Figure 1E). PPARg2 target genes, fatty acid-binding
protein-4 (aP2), adiponectin (ADIPOQ), and PPARg2 mRNA
were also significantly decreased in the presence of MitoCP at
days 3, 5 (Figure S1B), and 7 of differentiation after treatment
with MITOCP (Figure 1F). Similar results were observed in the
well-established 3T3L1 model of adipocyte differentiation (Fig-
ure S2). These results demonstrate that mitochondrial ROS
are required for activation of the transcriptional machinery that
regulates adipocyte differentiation.
Exogenous H2O2 Rescues Adipocyte Differentiation
in the Presence of Mitochondrial Antioxidants
If mitochondrial ROS are indeed upstream of transcriptional
programming during adipocyte differentiation, then overexpres-
sion of PPARg2 should circumvent the inhibition of adipocyte
differentiation observed in adipocytes treated with MitoCP.
PPARg2 is known as the master transcriptional regulator of
adipocyte differentiation (Rosen et al., 2000). Adenovirus ex-
pressing PPARg2 (AdPPARg2) or control null adenovirus
(AdNull) was infected into human MSCs at day 1. The PPARg
agonist troglitazone (Tro.) was also added to adipogenic media
to boost the efficacy of AdPPARg2-mediated transcription.
Human MSCs infected with AdPPARg2 or AdNull were treated
with MitoCP or TPP control starting at day 2 of differentiation.
AdPPARg2 + Tro. was effectively able to increase lipid accumu-
lation and induction of adipogenic genes in the presence of
MitoCP (Figures 2A–2C). Hydrogen peroxide is the major form
of ROS that triggers redox-dependent signaling in the cytosol
(Rhee, 2006). Mitochondrial-targeted antioxidants MitoCP and
MitoCTPO detoxify superoxide within mitochondria, thus pre-
venting their release and subsequent accumulation of H2O2
within the cytosol. We reasoned that if H2O2 was the major
form of ROS required for adipocyte differentiation then we
should be able to rescue the diminished adipocyte differentiation
induced by MitoCP by administering exogenous peroxide that
would rapidly enter the cytosol. In the presence of D-galactose,
galactose oxidase (GAO) produces hydrogen peroxide in the
culture media, which rapidly enters the cytosol (Wang et al.,
1998). Human MSCs treated with D-galactose (0.5 mM) and
GAO (0.015 U/ml) to continuously generate exogenous H2O2
starting at day 2 displayed an increase in intracellular H2O2 in
the presence of MitoCP at day 3 of differentiation (Figure 2D).
Importantly, this increased both lipid accumulation and induction
of adipogenic genes in the presence of MitoCP (Figures 2E and
2F). Collectively our data suggest that mitochondrial electron
transport chain generates superoxide, which is converted to
H2O2 to initiate the PPARg transcriptional machinery that regu-
lates adipocyte differentiation.
Mitochondria Complex III ROS Is Required for Activation
of Adipogenic Transcriptional Machinery
Mitochondria can generate ROS at complexes I, II, and III.
Complexes I and II produce superoxide within the matrix (Brand,Cell2010). Complex III has the ability to generate superoxide within
the matrix or intermembrane space (Brand, 2010). Complex III-
generated superoxide in the intermembrane space can escape
into the cytosol. Complex III has 11 subunits including Rieske
iron sulfur protein (RISP) and ubiquinone binding protein (QPc)
and generates superoxide as it conducts the ubiquinone (Q)
cycle. RISP is required for superoxide generation during the Q
cycle, while the function of the QPc is downstream of superoxide
generation (Figure 3A). Lentiviral infection of shRNA-targeting
RISP and QPc diminished protein levels (Figure 3B) and as
expected decreased both the basal and the maximal OCR to
similar levels (Figure 3C). Knocking down RISP diminished
ROS production, while knocking down QPc maintained ROS
production in human MSCs (Figure 3D). PPARg mRNA- and
PPARg-dependent gene targets were significantly attenuated
in RISP shRNA-expressing human MSCs undergoing adipocyte
differentiation compared to the QPc shRNA-expressing cells
and control-infected cells (Figure 3E). Similar results were ob-
tained with a second shRNA targeting RISP and QPc (Figures
S3A–S3C). Pharmacologic inhibitionwith the complex III inhibitor
antimycin, which is known to diminish oxygen consumption
but maintains superoxide production from complex III (Turrens
et al., 1985), also did not attenuate PPARg-dependent gene
targets (Figure S3D). Importantly, mitochondrial-targeted anti-
oxidants abolished the increase in PPARg-mediated tran-
scription in the presence of antimycin A (Figure S3E). These
results indicate that PPARg-dependent transcription during
adipocyte differentiation is dependent on mitochondrial com-
plex III-generated superoxide but independent of oxidative
phosphorylation.
mTORC1 Is Required for the Early Increase in ROS
during Adipocyte Differentiation
PI3-kinase signaling pathway and its downstream effector
mTORC1 are well-characterized regulators of lipogenesis and
PPARg-dependent transcription during adipocyte differentiation
(Laplante and Sabatini, 2009). In concordance with previous
studies in human MSCs (Yu et al., 2008), PPARg and C/EBPa
protein levels were decreased at days 5 and 7 after treatment
with PI3K inhibitor LY-294002 or mTORC1 inhibitor rapamycin
(Figure 4A). Next, we investigated whether PI3K and mTORC1
signaling results in an increase in mitochondrial oxygen con-
sumption and ROS during adipocyte differentiation. Human
MSCs undergoing adipocyte differentiation treated with LY-
294002 or rapamycin starting at day 2 displayed diminished
mitochondrial oxygen consumption at day 7 compared with
DMSO control (Figure 4B). Rapamycin diminished intracellular
H2O2 production at day 3 (Figure 4C). Also, we observed an
increase in mitochondrial biogenesis assessed by the ratio mito-
chondrial DNA (COXI gene) to nuclear DNA (PPRC1 gene) at day
3 compared to day 0, which was in part diminished by rapamycin
(Figure 4D). We genetically confirmed the positive regulation of
mTORC1 on mitochondrial ROS by knocking down raptor, an
essential component of mTORC1. Diminishing raptor levels in
human MSCs decreases ROS production, indicating that
mTORC1 is required for the increase in ROS production during
adipocyte differentiation (Figures 4E and 4F).
A likely contributor to the increase in mitochondrial ROS early
during adipocyte differentiation is mTORC1-dependent proteinMetabolism 14, 537–544, October 5, 2011 ª2011 Elsevier Inc. 539
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Figure 2. Exogenous PPARg or H2O2 Rescues Adipocyte Differentiation in the Presence of Mitochondrial-Targeted Antioxidants
(A) Human MSCs were infected with AdPPARg2 or AdNull at day 1 and treated with TPP (500 nM) or MitoCP (500 nM) ± 5 mM troglitazone (Tro) starting at day 2.
Subsequently, at day 21 of differentiation cells were stained with oil red O and optical density (OD) values were assessed. N = 3 ± SEM.
(B) Gene expression of PPARg2 and its target genes at day 7 of differentiation in human MSCs infected with AdPPARg2 or AdNull at day 1 and treated with TPP
(500 nM) or MitoCP (500 nM) ± 5 mM troglitazone (Tro.) starting at day 2. N = 3 ± SEM.
(C) Western blot analysis of PPARg protein at day 5 of adipocyte differentiation. HumanMSCs were infected with AdNull or AdPPARg2 at day 1 and administered
500 nM of MitoCP or TPP control starting at day 2.
(D) Intracellular H2O2 levels of human MSCs treated with galactose (0.5 mM) with or without galactose oxidase (GAO, 0.015 U/ml) in the presence of 500 nM TPP
or MitoCP starting at day 2. N = 3 ± SEM.
(E) HumanMSCs were treated with galactose (0.5 mM) with or without GAO (0.015 U/ml) plus 500 nM of TPP or MitoCP starting at day 2. Subsequently, at day 21
of differentiation cells were stained with oil red O and optical density (OD) values were assessed. N = 3 ± SEM.
(F) Human MSCs were treated with galactose (0.5 mM) with or without GAO (0.015 U/ml) plus 500 nM TPP or MitoCP starting at day 2. Gene expression was
analyzed at day 7 of differentiation. N = 3 ± SEM.
Cell Metabolism
Mitochondrial ROS Regulate Adipogenesistranslation, which increases cellular ATP demand and thereby
oxygen consumption. Cyclohexamide inhibition of protein
translation inhibition slightly diminished mitochondrial ROS
generation during differentiation (Figure S4A). It is possible
that mTORC1 might directly affect mitochondrial function, as
we observed a pool of raptor in the mitochondrial fraction (Fig-
ure S4B), indicating the proximity of this complex to mitochon-
dria. Interestingly, adenoviral PPARg infection did not rescue
adipogenesis in the presence of PI3K or mTORC1 inhibition
(Figures S4C and S4D), in contrast to the rescue observed in
the presence of mitochondrial antioxidants (Figures 2A–2C).540 Cell Metabolism 14, 537–544, October 5, 2011 ª2011 Elsevier InThus, effectors other than ROS are also activated by mTORC1
which are also required for adipocyte differentiation.
DISCUSSION
Chronic elevated levels of ROSwithin a cell have been attributed
to diseases including obesity and diabetes (Furukawa et al.,
2004; Houstis et al., 2006). Much of these previous studies
have suggested ROS as initiators of cellular damage. We and
others have proposed that low levels of ROS can serve as sig-
nalingmolecules to regulate physiology such as oxygen sensing,c.
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Figure 3. Mitochondrial Complex III ROS Are Required for Adipocyte Differentiation
(A) Mitochondrial complex III generates ROS through the ubiquinone (Q) cycle. The Q cycle generates superoxide through the donation of an electron from
ubisemiquinone (Q$) to oxygen. Loss of RISP subunit abolishes the generation of Q$ and thus superoxide. By contrast, loss of the QPc subunit maintains
superoxide production since it functions downstream from the formation of Q$ and superoxide.
(B) Western blot showing efficacy of stably transfected shRNA targeted against RISP or QPc in human MSCs.
(C) Mitochondrial OCR is decreased in RISP and QPC knockdown MSCs. Cells were treated with FCCP (10 mM) to obtain maximal OCRs. N = 3 ± SEM.
(D) Intracellular H2O2 measured at day 2 of differentiation in human MSCs infected with RISP or QPc shRNA. N = 5 ± SEM.
(E) Real-time PCR analysis ofPPARg2 and its target genes at day 7 of differentiation in humanMSCs inflected with scrambled, RISP, or QPc shRNA. N = 3 ± SEM.
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Mitochondrial ROS Regulate Adipogenesiswhile at higher levels ROS cause damage (Finkel, 2011). Further-
more, our knowledge of ROS has become more complicated in
the past decade, as the type of ROS and the compartmentaliza-
tion of ROS are likely to regulate distinct biological outcomes
(Hamanaka and Chandel, 2010).
In our current study we uncovered a physiologic role of mito-
chondrial-generated ROS in regulating adipocyte differentia-
tion. We observed that early during adipocyte differentiation
there is an mTORC1-dependent increase in mitochondrial
metabolism and biogenesis. A consequence of this increase
is the production of mitochondrial complex III ROS resulting
in the induction of PPARg transcriptional machinery required
to initiate adipocyte differentiation (Figure 4G). Although we
observe a positive correlation between mTORC1 and mito-
chondrial metabolism and ROS signaling, recent studies from
Shadel and colleagues demonstrate that reduced TORC1
signaling leads to an increase in respiration and ROS signaling
in yeast (Bonawitz et al., 2007; Pan et al., 2011). This could
reflect a metabolic difference between mammalian cells and
yeast, primarily the strong induction of the Crabtree effect
observed in yeast. Nevertheless, these studies in yeast and
our current study in mammalian cells conceptually advanceCellthe idea that TORC1 can control mitochondrial ROS to initiate
signaling.
It has been noted that stem cells undergo an increase in mito-
chondrial biogenesis and metabolism upon differentiation (St
John et al., 2005). This has led to the hypothesis that an increase
in mitochondrial metabolism is required to meet the energy
demands of differentiation. Our results indicate that an increase
in mitochondrial metabolism is not only necessary for energetic
demands but is causal in promoting differentiation through the
production of ROS. The broader implication of our findings is
that increased ROS levels provide a permissive oxidative envi-
ronment for signaling that initiates cellular differentiation. Mito-
chondrial ROS have been linked to differentiation during hemato-
poiesis inDrosophila (Owusu-Ansah and Banerjee, 2009). Future
studies will shed light as to whether an increase in mitochondrial
ROS is a general requirement for cellular differentiation.EXPERIMENTAL PROCEDURES
Cell Culture and Reagents
Human MSCs were obtained from Lonza and cultured according to manufac-
turers’ instructions. To induce adipocyte differentiation, cells were cultured inMetabolism 14, 537–544, October 5, 2011 ª2011 Elsevier Inc. 541
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Figure 4. mTORC1 Positively Regulates ROS Production during Adipocyte Differentiation
(A) Western blot analysis for PPARg expression and C/EBPa expression of humanMSCs treated with LY294002 (20 mM) or rapamycin (10 nM) starting at day 2 of
differentiation. Day 2 cells were treated for 4 hr prior to protein isolation.
(B) Mitochondrial OCR was analyzed at day 7 of adipocyte differentiation in humanMSCs treated with DMSO, LY-294002 (20 mM), or rapamycin (10 nM) at day 2.
Cells were treated with FCCP (10 mM) to obtain maximal OCRs. N = 4 ± SEM.
(C) Amplex Red analysis of intracellular H2O2 assessed at day 3 in humanMSCs treated with DMSO, rapamycin (10 nM), and LY294002 (20 mM) starting at day 2.
N = 4 ± SEM.
(D) Mitochondrial copy number as assessed by the ratio of mitochondrial geneCOXI to nuclear genePPRC1 at day 0 (4 hr) and day 3 of differentiation. Rapamycin
(10 nM) was added at starting at day 2. N = 6 ± SEM.
(E) Western blot showing efficacy of transfected shRNA targeted against raptor in human MSCs.
(F) Intracellular H2O2 measured at day 2 of differentiation is decreased in human MSCs infected with raptor shRNA. N = 5 ± SEM.
(G) mTORC1-dependent increase in mitochondrial complex III ROS is required for PPARg-dependent transcription during adipocyte differentiation.
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Mitochondrial ROS Regulate Adipogenesishigh-glucose (25 mM) Dulbecco’s modified Eagle’s medium (DMEM-HG)
supplemented with 5% fetal bovine serum, 2% HEPES, and 1% penicillin-
streptomycin. The adipogenic differentiation media also contained 200 mM
indomethacin (INDMT), 1 mM dexamethasone (DEX), 10 mg INS, and 0.5 mM
IBMX, which were all purchased from Sigma-Aldrich USA. Rapamycin,
LY-294002, FCCP, antimycin, and rotenone were purchased from Sigma.
Oil Red O Assays to Determine Lipid Accumulation
Human MSCs were incubated in adipogenic differentiation media for 21 days.
Subsequently, cells were stained with oil red O using the adipogenesis assay
kit (Millipore) as per the manufacturer’s instructions and quantified at 492 nm
using the Multiskan MCC plate reader (Fisher).
Real-Time RT-PCR Analysis
RNA was extracted using TRIzol Reagent (Invitrogen) according to manufac-
turers’ instructions. Of RNA, 2 mg per sample was made into cDNA using
MMLV reverse transcriptase (Applied Biosystems). Prepared cDNA was
amplified using the Bio-Rad iCycler iQ system (Bio-Rad Laboratories) and
analyzed using the SYBR Green PCR Master Mix (Applied Biosystem). PCR
primers were designed using Beacon Designer 3.01 software (Premier Biosoft
international) and are listed in the Supplemental Information. Cycle threshold542 Cell Metabolism 14, 537–544, October 5, 2011 ª2011 Elsevier In(Ct) values were normalized for amplification using mitochondrial ribosomal
protein L19, and the data were analyzed using the DCt method.
Immunoblot Analysis
Protein levels were analyzed in whole-cell lysates obtained using cell lysis
buffer (Cell Signaling), and samples were resolved on a SDS polyacrylamide
gel. Gels were analyzed by immunoblotting with antibodies for p44/p42
MAPK, raptor, PPARg, and C/EBPa (Cell Signaling); RISP monoclonal anti-
body (MitoSciences); and QPc (Proteintech).
Mitochondrial Assays
Seahorse bioscience extracellular flux (XF24) analyzer was utilized to measure
OCRs. Cells were plated in 24-well plates custom designed for XF24 analysis
at a density of 2–3 3 104. Mitochondrial oxygen consumption was calculated
by subtracting the residual rate after antimycin (1 mM) + rotenone (1 mM) treat-
ment. Mitochondrial biogenesis was assessed by measuring mitochondrial
DNA copy number as previously described (Li et al., 2005).
Adenoviral Infection of Human MSCs
Adenovirus PPARg was obtained from Vector BioLabs, and adenovirus null
was obtained from ViraQuest Inc. HumanMSCswere infected with adenovirusc.
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reagent (Stratagene) as previously described (Bosch and Stice, 2007).
shRNA and Generation of Stable Cell Lines
The pLKO.1-validated lentiviral vectors were obtained from Sigma to express
shRNA targeting human RISP, QPc, and raptor. Stable cell lines were gener-
ated by infection using viral supernatants from 293FT packaging cells followed
by puromycin selection. For raptor shRNA delivery, constructs were trans-
fected using GeneJammer Transfection reagent (Stratagene) according to
the manufacturer’s instructions. The shRNA sequences are provided in the
Supplemental Information.
ROS Measurement
Intracellular ROSwasmeasured using Amplex Red (Invitrogen) in lysed cells as
previously described (Bell et al., 2007).
Statistical Analysis
One-way analysis of variance was performed in Origin 7 to determine the pres-
ence of significant differences in the data. When analysis of variance indicated
that a significant difference was present, two-sample Student’s t tests were
performed to compare experimental data with appropriate controls. Statistical
significance was determined at a value of p < 0.05 and is represented with an
asterisk. Error bars are defined as standard error of the mean (SEM).
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/
j.cmet.2011.08.007.
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